Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CBUS vs MOS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MOS Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 7–3 Matrix Metrics)

MOS Overall Winner 6-Pillar Tally: CBUS 0 – 6 MOS Matrix Metrics: CBUS 3 – 7 MOS

As of Nov 20, 2026, The Mosaic Company (MOS) is the stronger overall head-to-head candidate over Cibus, Inc. (CBUS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CBUS carries a Unified Composite Score of 50.9/100 (HOLD) at $1.21 (N/M Forward P/E, -1125.5% operating margin), whereas MOS carries 41.3/100 (SELL) at $18.66 (14.9x Forward P/E, -0.2% operating margin).

  • Composite vs. Pillar Nuance: While CBUS currently prints a higher short-term Unified Composite Score (50.9/100 HOLD vs. MOS 41.3/100 SELL), MOS captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-0.2% vs. -1125.5% operating margin) and revenue trajectory (-10.2% vs. +30.1% YoY).
  • Technical & Structure Timing Caution: CBUS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 44.6); meanwhile MOS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CBUS vs MOS
CBUS NASDAQ
Cibus, Inc. Class A Common Stock
Agricultural Chemicals
$1.21
-1.63% 1D
Market Cap $94.3M
TTM Revenue $4.5M
Forward P/E N/M
Beta / 30D Vol 1.75β · 94% Vol
Unified Composite Score
50.9 / 100 HOLD
Tech 60.0 Fund 52.0 Flow 59.0 Mom 54.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.2%), weak momentum, RSI 45
RSI-14: 44.6 · SMA20: $1.24 · SMA50: $1.40
MOS NYSE Head-to-Head Winner
The Mosaic Company
Agricultural Chemicals
$18.66
-5.99% 1D
Market Cap $6.3B
TTM Revenue $11.9B
Forward P/E 14.9x
Beta / 30D Vol 0.82β · 75% Vol
Unified Composite Score
41.3 / 100 SELL
Tech 20.0 Fund 46.0 Flow 57.0 Mom 74.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.7%), weak momentum, RSI 38
RSI-14: 37.7 · SMA20: $20.39 · SMA50: $20.92

6-Pillar Scorecard Institutional Category Breakdown (CBUS 0 – 6 MOS)

Columns: Metric · CBUS · MOS
1. Valuation Multiples MOS
Forward P/E N/M 14.9x
Trailing P/E N/M 18.1x
PEG Ratio N/M 2.12x
EV / Revenue 21.2x 1.0x
2. Growth & Scale MOS
Revenue Growth (YoY) +30.1% -10.2%
Earnings Growth (YoY) +0.0% +239.5%
TTM Revenue (USD) $4.5M $11.9B
Market Cap $94.3M $6.3B
3. Profitability & Quality MOS
Gross Margin 100.0% 7.6%
Operating Margin -1125.5% -0.2%
Net Profit Margin 0.0% -9.4%
Return on Equity (ROE) -419.6% -9.0%
4. Balance Sheet & Cash Flow MOS
Cash Generation (TTM) -$51M -$808M
Cash Flow Margin N/A -6.8%
Net Cash / Leverage $1.8M Net Debt (0.90x D/E) $5.85B Net Debt (0.54x D/E)
Dividend Yield None (0.00%) 4.42%
5. Options & Positioning MOS
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile 110.1% (50th %ile) 51.7% (25th %ile)
Put/Call OI Skew N/A 0.99x (Balanced)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat MOS
OpEx & R&D Intensity N/A 7.8% of Rev ($928M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Agricultural Inputs Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CBUS (3) vs MOS (7)
Institutional Metric CBUS MOS Criterion Row Edge
Market Capitalization
Scale
$94.3M $6.3B Larger Scale MOS
Trailing P/E Ratio
Valuation
N/M 18.1x Lower Multiple MOS
Forward P/E Ratio
Valuation
N/M 14.9x Lower Multiple MOS
Revenue Growth (YoY)
Growth
+30.1% -10.2% Higher Growth CBUS
Operating Margin (TTM)
Profitability
-1125.5% -0.2% Higher Margin MOS
Net Profit Margin
Profitability
0.0% -9.4% Higher Margin CBUS
Return on Equity (ROE)
Capital Efficiency
-419.6% -9.0% Higher ROE MOS
52-Week Range Position
Momentum
6% ($1–$4) 11% ($17–$32) Stronger Trend MOS
Beta / 30D Volatility
Risk Regime
1.75β · 94% Vol 0.82β · 75% Vol Lower Realized Risk MOS
Unified Institutional Score
Composite Signal
50.9 / 100 (HOLD) 41.3 / 100 (SELL) Higher Composite CBUS
Trailing 12M Revenue (USD)
Operating Scale
$4.5M $11.9B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 7.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 21.2x EV/Rev 2.12x PEG · 1.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$51M ($1.8M Net Debt (0.90x D/E)) -$808M ($5.85B Net Debt (0.54x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MOS +21.62 pp
CBUS: -13.57% · MOS: +8.05%
3M Horizon MOS +7.81 pp
CBUS: -30.06% · MOS: -22.25%
6M Horizon CBUS +4.78 pp
CBUS: -12.32% · MOS: -17.1%
1Y Horizon CBUS +19.12 pp
CBUS: -4.72% · MOS: -23.84%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CBUS Revenue MOS Revenue CBUS Op. Margin MOS Op. Margin Margin Leader
FY2018 $0M $9.59B -11913.1% 9.7% MOS
FY2019 $10M $8.91B -543.8% -12.3% MOS
FY2020 $20M $8.68B -183.8% 4.8% MOS
FY2021 $30M $12.4B -112.9% 20.0% MOS
FY2022 $0M $19.1B -14248.4% 25.0% MOS
FY2023 $0M $13.7B -17550.0% 9.8% MOS
FY2024 $0M $11.1B -6062.8% 5.6% MOS
FY2025 $0M $12.1B -2680.1% 6.8% MOS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CBUS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 110.1%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CBUS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MOS SURGE
8d in phase · OBV DISTRIBUTION
Current IV 51.7%
IV Percentile 25th %ile
Put/Call OI Skew 0.99x (Balanced)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact MOS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $21.23 · IV 50.0%

MOS Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($2,123)

Compare $2,123 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 50.0% ATM IV.

5-DAY BULLISH SWING Liq A

Dec 18 $21 / $24 Bull Call Spread

Buy 1x $21C · Sell 1x $24C · 31d

Net Entry $94 Debit
T+5d @ +5% Move +$40 (+43%)
Max Risk / Buffer $94 Capped
5d Edge & Liquidity 0.9x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $19 / $17.5 Bull Put Spread

Sell 2x $19P · Buy 2x $17.5P · 31d

Net Entry $64 Credit
Max Credit / Yield +$64 (+27.1% RoM)
Max Risk / Buffer -12.0% Cushion ($236 Mgn)
5d Edge & Liquidity 79% PoP · Liq A
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq A

Dec 18 $19P / $21-$24C Seagull

Sell 1x $19P · Buy 1x $21/$24C · 31d

Net Entry $49 Debit
T+5d @ +5% Move +$66 (+22.2% RoM)
Max Risk / Buffer -10.5% Put Cushion ($296 Mgn)
5d Edge & Liquidity 0.9x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CBUS Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $94.3M market capitalization and -1125.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
MOS Moat Profile Cyclical / Execution-Driven Positioning
Agricultural Inputs Operator
Competes within the Agricultural Inputs value chain with $6.3B market capitalization and -0.2% operating margin.
OpEx & R&D Reinvestment 7.8% of Rev ($928M)
90D Engineering Disclosures 0 Published

Investor FAQ CBUS vs MOS Key Questions & Quantitative Answers

As of Nov 20, 2026, The Mosaic Company (MOS) is the stronger overall head-to-head candidate over Cibus, Inc. (CBUS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CBUS carries a Unified Composite Score of 50.9/100 (HOLD) at $1.21 (N/M Forward P/E, -1125.5% operating margin), whereas MOS carries 41.3/100 (SELL) at $18.66 (14.9x Forward P/E, -0.2% operating margin). Composite vs. Pillar Nuance: While CBUS currently prints a higher short-term Unified Composite Score (50.9/100 HOLD vs. MOS 41.3/100 SELL), MOS captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-0.2% vs. -1125.5% operating margin) and revenue trajectory (-10.2% vs. +30.1% YoY). Technical & Structure Timing Caution: CBUS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 44.6); meanwhile MOS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MOS leads the Growth & Scale pillar: CBUS posts +30.1% YoY revenue growth and +0.0% YoY earnings growth on $4.5M TTM revenue (100.0% gross margin, -1125.5% operating margin), compared with MOS at -10.2% YoY revenue growth and +239.5% YoY earnings growth on $11.9B TTM revenue (7.6% gross margin, -0.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CBUS cumulative revenue shifted +200.0% while MOS shifted +25.7%. In operating R&D and SG&A reinvestment, CBUS deploys N/A (0 90-day corporate R&D disclosures) versus 7.8% of Rev ($928M) (0 disclosures) for MOS.

MOS screens cheaper on headline valuation multiples. CBUS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 21.2x EV/Revenue (unreported FCF margin), whereas MOS trades at 14.9x Forward P/E, 18.1x Trailing P/E, 2.12x PEG, and 1.0x EV/Revenue (-6.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CBUS (-419.6% ROE) versus MOS (-9.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CBUS carries 110.1% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.75β · 94% Vol realized risk). By comparison, MOS carries 51.7% implied volatility (25th %ile, Balanced (25th–60th %ile)), a 0.99x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.82β · 75% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.